CL2014000802A1 - Proceso para la preparacion de estetrol, util para terapia de reemplazo hormonal y la anticoncepcion. - Google Patents
Proceso para la preparacion de estetrol, util para terapia de reemplazo hormonal y la anticoncepcion.Info
- Publication number
- CL2014000802A1 CL2014000802A1 CL2014000802A CL2014000802A CL2014000802A1 CL 2014000802 A1 CL2014000802 A1 CL 2014000802A1 CL 2014000802 A CL2014000802 A CL 2014000802A CL 2014000802 A CL2014000802 A CL 2014000802A CL 2014000802 A1 CL2014000802 A1 CL 2014000802A1
- Authority
- CL
- Chile
- Prior art keywords
- estetrol
- contraception
- useful
- preparation
- replacement therapy
- Prior art date
Links
- AJIPIJNNOJSSQC-NYLIRDPKSA-N estetrol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)[C@@H]4O)O)[C@@H]4[C@@H]3CCC2=C1 AJIPIJNNOJSSQC-NYLIRDPKSA-N 0.000 title 1
- 229950009589 estetrol Drugs 0.000 title 1
- 238000002657 hormone replacement therapy Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161544591P | 2011-10-07 | 2011-10-07 | |
| EP11184278 | 2011-10-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014000802A1 true CL2014000802A1 (es) | 2014-11-14 |
Family
ID=48043195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014000802A CL2014000802A1 (es) | 2011-10-07 | 2014-04-02 | Proceso para la preparacion de estetrol, util para terapia de reemplazo hormonal y la anticoncepcion. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8987484B2 (es) |
| EP (1) | EP2764008B1 (es) |
| JP (1) | JP6196625B2 (es) |
| KR (1) | KR102007874B1 (es) |
| CN (1) | CN103890001B (es) |
| AU (1) | AU2012320423C1 (es) |
| BR (1) | BR112014008196B8 (es) |
| CA (1) | CA2847813C (es) |
| CL (1) | CL2014000802A1 (es) |
| CY (1) | CY1118674T1 (es) |
| DK (1) | DK2764008T3 (es) |
| EA (1) | EA024003B1 (es) |
| ES (1) | ES2593316T3 (es) |
| HR (1) | HRP20161282T1 (es) |
| HU (1) | HUE028963T2 (es) |
| IN (1) | IN2014MN00841A (es) |
| LT (1) | LT2764008T (es) |
| ME (1) | ME02527B (es) |
| MX (1) | MX348917B (es) |
| PL (1) | PL2764008T3 (es) |
| PT (1) | PT2764008T (es) |
| RS (1) | RS55231B1 (es) |
| SG (1) | SG11201401282PA (es) |
| SI (1) | SI2764008T1 (es) |
| SM (1) | SMT201600375B (es) |
| WO (1) | WO2013050553A1 (es) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10660903B2 (en) | 2015-06-18 | 2020-05-26 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
| US10894014B2 (en) | 2015-06-18 | 2021-01-19 | Estetra Sprl | Orodispersible tablet containing Estetrol |
| US11053274B2 (en) | 2011-06-01 | 2021-07-06 | Estetra S.P.R.L. | Process for the production of estetrol intermediates |
| US11053273B2 (en) | 2011-06-01 | 2021-07-06 | Estetra S.P.R.L. | Process for the production of estetrol intermediates |
| US11147771B2 (en) | 2015-06-18 | 2021-10-19 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
| US11452733B2 (en) | 2018-04-19 | 2022-09-27 | Estetra Sprl | Compounds and their uses for alleviating menopause-associated symptoms |
| US11484539B2 (en) | 2018-04-19 | 2022-11-01 | Estetra Sprl | Compounds and their uses for alleviating menopause-associated symptoms |
| US11896602B2 (en) | 2016-08-05 | 2024-02-13 | Estetra Srl | Method for preventing pregnancy |
| US12458649B2 (en) | 2020-04-16 | 2025-11-04 | Estetra Srl | Contraceptive compositions with reduced adverse effects |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| WO2013034780A2 (en) * | 2012-12-20 | 2013-03-14 | Crystal Pharma, S.A.U. | Process for the preparation of estetrol and related compounds |
| WO2015040051A1 (en) | 2013-09-18 | 2015-03-26 | Crystal Pharma, S.A.U. | Process for the preparation of estetrol |
| MD3310346T2 (ro) * | 2015-06-18 | 2021-06-30 | Estetra Sprl | Comprimată orodispersabilă ce conține estetrol |
| EP3647413A1 (en) * | 2018-10-31 | 2020-05-06 | Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas O.A., M.P. (CIEMAT) | Improvements for performing and facilitating the recovery after hematopoietic stem cell transplantation |
| HU231240B1 (hu) | 2019-09-03 | 2022-04-28 | Richter Gedeon Nyrt. | Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására |
| IT201900017414A1 (it) | 2019-09-27 | 2021-03-27 | Ind Chimica Srl | Processo per la preparazione di (15α,16α,17β)-estra-1,3,5(10)-triene-3,15,16,17-tetrolo (Estetrolo) ed intermedi di detto processo |
| IT201900021879A1 (it) | 2019-11-22 | 2021-05-22 | Ind Chimica Srl | PROCESSO PER LA PREPARAZIONE DI (15α,16α,17β)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROLO (ESTETROLO) ED INTERMEDI DI DETTO PROCESSO |
| JP7588140B2 (ja) * | 2019-09-27 | 2024-11-21 | インダストリアレ チミカ ソシエタ ア レスポンサビリタ リミタータ | （１５α，１６α，１７β）－エストラ－１，３，５（１０）－トリエン－３，１５，１６，１７－テトロール（エステトロール）および当該製法の中間体を調製するためのプロセス |
| IT202100019631A1 (it) | 2021-07-23 | 2023-01-23 | Newchem S P A | Metodo per produrre estetrolo e i suoi intermedi |
| WO2023021026A1 (en) * | 2021-08-17 | 2023-02-23 | Aspen Oss B.V. | A synthetic pathway to estra-1,3,5(10)-triene-3,15a,16a,17b-tetrol |
| CN118251402A (zh) | 2021-10-01 | 2024-06-25 | 工业化学有限公司 | 制备(15α,16α,17β)-雌甾-1,3,5(10)-三烯-3,15,16,17-四醇（雌四醇）一水合物的方法 |
| AU2023428138A1 (en) | 2023-02-02 | 2025-09-04 | Industriale Chimica S.R.L. | PROCESS FOR PREPARING (15α,16α,17β)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROL (ESTETROL) MONOHYDRATE |
| WO2025046071A1 (en) * | 2023-08-30 | 2025-03-06 | Estetra Srl | Process for the production of estetrol intermediates |
| TW202533830A (zh) | 2024-02-28 | 2025-09-01 | 比利時商埃斯特拉有限公司 | 雌四醇多晶型及其生產 |
| HUP2400151A1 (hu) | 2024-02-28 | 2025-09-28 | Richter Gedeon Nyrt | Ösztetrol-monohidrát kristályosítási eljárás |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW548277B (en) * | 1999-07-16 | 2003-08-21 | Akzo Nobel Nv | Orally active androgens |
| WO2001040255A2 (en) * | 1999-12-02 | 2001-06-07 | Akzo Nobel N.V. | 14,15-beta-methylene substituted androgens |
| ES2346053T3 (es) | 2002-11-08 | 2010-10-08 | Pantarhei Bioscience B.V. | Sintesis de esterol a traves de esteroides derivados de estrona. |
| UA89964C2 (ru) * | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
| WO2012164095A1 (en) | 2011-06-01 | 2012-12-06 | Estetra S.A. | Process for the production of estetrol intermediates |
| AU2012264602B2 (en) | 2011-06-01 | 2017-03-09 | Estetra Srl | Process for the production of estetrol intermediates |
| EP2383279A1 (en) * | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
-
2012
- 2012-10-05 AU AU2012320423A patent/AU2012320423C1/en active Active
- 2012-10-05 PL PL12778664T patent/PL2764008T3/pl unknown
- 2012-10-05 CN CN201280049319.2A patent/CN103890001B/zh active Active
- 2012-10-05 EP EP12778664.8A patent/EP2764008B1/en active Active
- 2012-10-05 MX MX2014003723A patent/MX348917B/es active IP Right Grant
- 2012-10-05 SG SG11201401282PA patent/SG11201401282PA/en unknown
- 2012-10-05 DK DK12778664.8T patent/DK2764008T3/en active
- 2012-10-05 ME MEP-2016-229A patent/ME02527B/me unknown
- 2012-10-05 PT PT127786648T patent/PT2764008T/pt unknown
- 2012-10-05 KR KR1020147007408A patent/KR102007874B1/ko active Active
- 2012-10-05 US US14/349,940 patent/US8987484B2/en active Active
- 2012-10-05 LT LTEP12778664.8T patent/LT2764008T/lt unknown
- 2012-10-05 CA CA2847813A patent/CA2847813C/en active Active
- 2012-10-05 BR BR112014008196A patent/BR112014008196B8/pt active IP Right Grant
- 2012-10-05 ES ES12778664.8T patent/ES2593316T3/es active Active
- 2012-10-05 SI SI201230705A patent/SI2764008T1/sl unknown
- 2012-10-05 WO PCT/EP2012/069761 patent/WO2013050553A1/en not_active Ceased
- 2012-10-05 JP JP2014533925A patent/JP6196625B2/ja active Active
- 2012-10-05 HR HRP20161282TT patent/HRP20161282T1/hr unknown
- 2012-10-05 HU HUE12778664A patent/HUE028963T2/en unknown
- 2012-10-05 EA EA201490713A patent/EA024003B1/ru unknown
- 2012-10-05 RS RS20160859A patent/RS55231B1/sr unknown
-
2014
- 2014-04-02 CL CL2014000802A patent/CL2014000802A1/es unknown
- 2014-05-05 IN IN841MUN2014 patent/IN2014MN00841A/en unknown
-
2016
- 2016-10-10 CY CY20161101001T patent/CY1118674T1/el unknown
- 2016-10-17 SM SM201600375T patent/SMT201600375B/it unknown
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11053274B2 (en) | 2011-06-01 | 2021-07-06 | Estetra S.P.R.L. | Process for the production of estetrol intermediates |
| US11053273B2 (en) | 2011-06-01 | 2021-07-06 | Estetra S.P.R.L. | Process for the production of estetrol intermediates |
| US11957694B2 (en) | 2015-06-18 | 2024-04-16 | Estetra Srl | Orodispersible dosage unit containing an estetrol component |
| US10894014B2 (en) | 2015-06-18 | 2021-01-19 | Estetra Sprl | Orodispersible tablet containing Estetrol |
| US11147771B2 (en) | 2015-06-18 | 2021-10-19 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
| US10660903B2 (en) | 2015-06-18 | 2020-05-26 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
| US11896602B2 (en) | 2016-08-05 | 2024-02-13 | Estetra Srl | Method for preventing pregnancy |
| US11452733B2 (en) | 2018-04-19 | 2022-09-27 | Estetra Sprl | Compounds and their uses for alleviating menopause-associated symptoms |
| US11484539B2 (en) | 2018-04-19 | 2022-11-01 | Estetra Sprl | Compounds and their uses for alleviating menopause-associated symptoms |
| US11666585B2 (en) | 2018-04-19 | 2023-06-06 | Estetra Srl | Compounds and their uses for alleviating menopause-associated symptoms |
| US12390478B2 (en) | 2018-04-19 | 2025-08-19 | Estetra Srl | Compounds and their uses for alleviating menopause-associated symptoms |
| US12458651B2 (en) | 2018-04-19 | 2025-11-04 | Estetra Srl | Compounds and their uses for alleviating menopause-associated symptoms |
| US12458649B2 (en) | 2020-04-16 | 2025-11-04 | Estetra Srl | Contraceptive compositions with reduced adverse effects |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2014000802A1 (es) | Proceso para la preparacion de estetrol, util para terapia de reemplazo hormonal y la anticoncepcion. | |
| HUS2200018I1 (hu) | Drospirenont tartalmazó gyógyszerkészítmény, fogamzásgátlóként történõ alkalmazásra | |
| ZA201309264B (en) | Controlled release nasal testosterone gels,methods and pre-filled multi-dose applicator systems for pernasal administration | |
| BR112013021368A2 (pt) | implante, especialmente para oclusão de abeurismas bifurcais | |
| BR112015002541A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente. | |
| BR112014001450A2 (pt) | dispositivos intravaginais para distribuição de droga | |
| IL234948A0 (en) | Equipment for tissue expansion systems and methods | |
| ZA201501541B (en) | Supported catalyst and active form thereof, and preparation method and use thereof | |
| IL233324A (en) | Dimeric compounds as agonist receptor for fgf, process for their preparation and medical use | |
| BR112015003397A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente. | |
| BRPI1016147A2 (pt) | sistema intrauterino para uso no tratamento de uma condição médica, e, método para a fabricação de um sistema intrauterino | |
| ZA201309101B (en) | Surgical anchor delivery system | |
| PL2672966T3 (pl) | Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania | |
| BR112013028856A2 (pt) | pinça para fixação de fraturas em ossos | |
| BR112014001274A2 (pt) | composto de hormônio luteinizante, e, composição farmacêutica | |
| CL2014003232A1 (es) | Formulaciones y métodos para la administración vaginal de antiprogestinas. | |
| ZA201405405B (en) | Humanized anti-epiregulin antibody,and cancer therapeutic agent comprising said antibody as active ingredient | |
| BR112013014203A2 (pt) | peptídeo anfifílico bicéfalo, hidrogel e método para liberação de um agente bioativo | |
| WO2013052647A3 (en) | Formulations and uses of retinoic acid receptor selective agonists | |
| BR112013017669A2 (pt) | di-hidrofuranos fundidos como moduladores de gpr119 para o tratamento de diabetes, obesidade e doenças relacionadas | |
| BR112013019631A2 (pt) | sistemas cirúrgicos e métodos para estes. | |
| GB201312344D0 (en) | Liposomal drug delivery system for bone cements | |
| EP2990040A4 (en) | Therapeutic agent for eyeground disease | |
| ES2641042T8 (es) | Procedimiento para la fabricación de un fármaco proteínico | |
| EP2982352A4 (en) | Cerclage pessary containing progesterone for prolonged, sustained and continuous release, used to prevent premature birth |